The 20 Best Localized Scleroderma Doctors Near Me in Chevy Chase, MD

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as a Distinguished provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma. Dr. Wigley is board certified in American Board Of Internal Medicine.

Dr. Ronald Sweren is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous lymphoma/mycosis fungoides, phototherapy/ photopheresis and melanoma. Dr. Sweren also serves as director of the Phototherapy/Photopheresis Program in the Department of Dermatology. Dr. Sweren earned his M.D. from the University of Maryland School of Medicine. He completed his residency in dermatology at University of Maryland Medical Center and in pediatrics at Sinai Hospital of Baltimore. Dr. Sweren is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), Melanoma, and T-Cell Lymphoma. Dr. Sweren is board certified in American Board Of Dermatology and American Board Of Pediatrics.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma. Dr. Hummers is board certified in American Board Of Internal Medicine.

Dr. Sima Rozati is an Assistant Professor of Dermatology at the Johns Hopkins University School of Medicine. She specializes in medical dermatology, cutaneous lymphoma, and supportive oncodermatology. She received her medical degree from the Shahid Beheshti University of Medical Sciences in Tehran. After completing her internal medicine residency at the Cleveland Clinic, she completed a research fellowship and PhD in cutaneous lymphoma at the University Hospital of Zürich in Switzerland. She returned to the U.S. where she completed cutaneous lymphoma fellowship, under the mentorship of Dr. Youn Kim, followed by dermatology residency at Stanford University School of Medicine in California. In a multidisciplinary environment, Dr. Rozati aims to provide excellent care to patients with cutaneous lymphoma and cancer whom are experiencing cutaneous adverse events from targeted therapies, immune- and chemotherapies. Dr. Rozati’s research interest focuses on cutaneous lymphoma, understanding the biology of this heterogeneous group of malignancies by analyzing the mutational and epigenetic landscape. Her translational research efforts is directed to investigate novel targeted and immunotherapeutic for cutaneous T cell lymphoma. She is a member of different professional organizations, including the American Academy of Dermatology and Woman’s dermatologic Society. Dr. Rozati is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Sezary Syndrome. Dr. Rozati is board certified in American Board Of Dermatology.

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut. He earned his M.D. from the American University of Beirut and his M.P.H. from the Johns Hopkins University School of Public Health. He completed a residency in internal medicine at Good Samaritan Hospital of Maryland and a residency in dermatology at Johns Hopkins. Dr. Alhariri is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Melanoma, Hidradenitis Suppurativa, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus. Dr. Alhariri is board certified in American Board Of Dermatology.

Jun Kang is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Kang is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), and Systemic Lupus Erythematosus (SLE). Dr. Kang is board certified in American Board Of Dermatology.

Zsuzsanna Mcmahan is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Mcmahan is rated as a Distinguished provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Localized Scleroderma, and Scleroma.

Charlotte Modly is a Dermatologist practicing medicine in Reisterstown, Maryland. Dr. Modly is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Rosacea, Localized Scleroderma, Malignant Hypertension, and Female Pattern Baldness.

Dr. Grant Anhalt is a professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include autoimmune skin diseases and dermatoimmunology. Dr. Anhalt serves as the director of the Dermatoimmunology Laboratory at the Johns Hopkins School of Medicine. He received his undergraduate degree and his M.D. from the University of Manitoba. He completed a residency in internal medicine at the Health Sciences Center in Winnipeg, Canada and a residency in dermatology at the University of Michigan. He performed a fellowship in immunodermatology at the University of Michigan Medical Center. Dr. Anhalt joined the Johns Hopkins faculty in 1982. He was interim chair of the Department of Dermatology from 1996 to 2001. His research interests include autoimmunity, bullous skin diseases and pemphigus and pemphigoid. Dr. Anhalt serves on the medical advisory board for the International Pemphigus & Pemphigoid Foundation. He has been recognized as a top doctor in the Washington Post Magazine, Baltimore Magazine and Castle Connolly Guide. He is a member of several professional organizations, including the American Academy of Dermatology, American Dermatologic Association and American Society for Clinical Investigation. CV http://www.hopkinsmedicine.org/dermatology/our_experts/CV/Anhalt_CV_2014.docx. Dr. Anhalt is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pemphigus Vulgaris, Pemphigus, Bullous Pemphigoid, and Pemphigus Foliaceus. Dr. Anhalt is board certified in American Board Of Dermatology.

Katherine Maher is a Rheumatologist practicing medicine in Rockville, Maryland. Dr. Maher is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Raynaud Phenomenon, and Sjogren Syndrome. Dr. Maher is board certified in Internal Medicine and Rheumatology.

Mark Davino, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Odenton. He received his medical degree from the University of Maryland School of Medicine, and also completed his residency in internal medicine & pediatrics at the University of Maryland Medical Center. Dr. Davino is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His clinical expertise encompasses Localized Scleroderma, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Glucocorticoid-Remediable Aldosteronism. Dr. Davino is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

Dr. Allan Gelber is Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in Clinical Investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University and then undertook his fellowship training in rheumatology at Johns Hopkins. Dr. Gelber has had an active role as an Educator in the Rheumatic Diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001-2011. Thereafter, he shifted his primary educational focus from rheumatology fellows to medical students, and to internal medicine housestaff on the Bayview and Johns Hopkins campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to the 2nd year medical school class. Currently, Dr. Gelber serves as Thayer Firm Faculty Leader of the Osler Medical Training Program. and among the Aliki Scholars at Johns Hopkins Bayview Medical Center. Dr. Gelber chairs the M.D. Admissions Committee at the School of Medicine. Dr. Gelber is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Gout, Arthritis, Scleroderma, Knee Replacement, and Endoscopy. Dr. Gelber is board certified in American Board Of Internal Medicine.

Dr. Joy Wan is an Assistant Professor of Dermatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include pediatric dermatology and atopic dermatitis. Dr. Wan received her undergraduate degree in biochemical sciences from Harvard University and her M.D. from the University of Pennsylvania. She completed dermatology residency training at the University of Pennsylvania and pediatric dermatology fellowship at the Children’s Hospital of Philadelphia. She also pursued postdoctoral research training in clinical epidemiology at the University of Pennsylvania. Dr. Wan joined the Johns Hopkins faculty in 2021. In addition to her clinical practice, Dr. Wan leads an active research program focused on epidemiologic and patient-oriented investigations of pediatric skin diseases including eczema. Dr. Wan is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Atopic Dermatitis, Infantile Digital Fibromatosis, PHACE Syndrome, and Psoriasis. Dr. Wan is board certified in American Board Of Dermatology.

Megan Casady is a Dermatologist practicing medicine in Annapolis, Maryland. Dr. Casady is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Neurocutaneous Melanosis.

Adey Berhanu is a Rheumatologist practicing medicine in Chevy Chase, Maryland. Dr. Berhanu is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Tenosynovitis, and Gout. Dr. Berhanu is board certified in Rheumatology and Internal Medicine.

"Dr. Elisabeth ""Betsy"" Richard is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include both general dermatology as well as medical dermatology, specializing in phototherapy and photomedicine. Dr. Richard received her undergraduate degree from Middlebury College in Vermont. She earned her medical degree from the University of Massachusetts Medical School. She completed an internship in internal medicine at Washington Hospital Center and a residency in dermatology at Johns Hopkins.". Dr. Richard is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Psoriasis, Plaque Psoriasis, Mycosis Fungoides, and Vitiligo. Dr. Richard is board certified in American Board Of Dermatology.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Scleroderma. Dr. Paik is board certified in American Board Of Internal Medicine.

"Daniel J. Lewis, M.D. is a dual fellowship-trained Mohs and reconstructive surgeon and Assistant Professor of Dermatology at Johns Hopkins University School of Medicine. He leads the Mohs surgery unit at the Johns Hopkins Outpatient Center (JHOC), the hospital's flagship facility in downtown Baltimore. He is also heavily involved in education as the director of the JHOC resident surgery clinic and as core faculty for the Micrographic Surgery and Dermatologic Oncology fellowship. Dr. Lewis earned a B.A. in Biology from the University of Pennsylvania, earned his M.D. at Baylor College of Medicine while completing a research fellowship at The University of Texas MD Anderson Cancer Center, and completed his internship at Memorial Sloan Kettering Cancer Center. He then returned to Penn for dermatology residency, serving as chief resident at the country's No. 1-ranked dermatology program by Doximity. At Penn, he pursued further specialization with two year-long post-doctoral fellowships in cutaneous oncology and Mohs micrographic surgery. During his Mohs fellowship at Penn, Dr. Lewis worked at the largest academic Mohs surgery center in the country alongside leaders in the field and pioneers in the use of Mohs surgery with immunohistochemistry, complex reconstruction, high-risk tumors, and tumors on specialty sites. Dr. Lewis has authored over 90 peer-reviewed manuscripts in high-impact journals such as Journal of the American Academy of Dermatology, JAMA Dermatology, and Journal of Investigative Dermatology. He has also served on the Editorial Board of the International Journal of Dermatology and has authored multiple textbook chapters as well as two editions of the book Practical Ways to Improve Patient Adherence, named the winner of the 2022 ""Best Overall"" Dermie Award by Dermasphere. Dr. Lewis is an aspiring leader in cutaneous oncology and was named Post-Doctoral Trainee of the Year in 2022 by ADEN, winner of the 2022 ASDS Young Investigators Writing Competition, and a Rising Scholar by the Dermatology Foundation in 2023. He is a member of the Alpha Omega Alpha Honor Medical Society. He is passionate about Mohs micrographic surgery and has clinical interests in advanced facial reconstruction, Mohs surgery with immunohistochemistry, facial anatomy, Merkel cell carcinoma, melanoma, and patient adherence.". Dr. Lewis is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome. Dr. Lewis is board certified in American Board Of Dermatology.

Dr. Sewon Kang is the Noxell Professor and Chairman of the Department of Dermatology at the Johns Hopkins University School of Medicine and the Dermatologist-in-Chief of Johns Hopkins Hospital. He is also founder and co-Director of the Cutaneous Translational Research Program (CTReP) at Hopkins. A recipient of the Dermatology Foundation's Career Development Award, he has received other research awards and grants from the American Dermatological Association, the National Psoriasis Foundation and the National Institutes of Health (Roadmap T32, K24, and R01). His research focus has been in the areas of skin pharmacology and photomedicine. He is the Past President of the Photomedicine Society, and the American Acne and Rosacea Society. Dr. Kang is or has been on the Board of Directors of multiple organizations including, the Society for Investigative Dermatology, the Association of Professors of Dermatology, the Dermatology Foundation, and the Skin of Color Society. An author on over 240 publications and book chapters, Dr. Kang is also the Editor-in-Chief of the 9th edition of the Fitzpatrick's Dermatology textbook. He is an inventor/co-inventor of 17 patents and has given over 300 presentations globally. A graduate with honors from Williams College and the University of Michigan, Dr. Kang completed dermatology residency and fellowship at the Harvard Medical School/Massachusetts General Hospital. He sees patients exclusively at the Johns Hopkins Hospital, and his areas of clinical expertise include photomedicine, skin cancer (melanoma), skin aging, and dermatology for ethnic skin. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Melanoma, Acne, Prurigo Nodularis, and Rosacea. Dr. Kang is board certified in American Board Of Dermatology.

Alan Matsumoto is a Rheumatologist practicing medicine in Silver Spring, Maryland. Dr. Matsumoto is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, Osteoporosis, and Juvenile Primary Osteoporosis.